___________________________________________________________________________ FIELD => | AGE | AGE | PSA>4 | URINARY | BIOPSY PROVEN | |RECORD | >30 YRS | >60 YRS | mEq/dL | COMPLAINT | PROSTATE CANCER | V | | | | | | ___________________________________________________________________________ ABBREV | AGE30 | AGE60 | PSAG4 | URCOM | PROCA | ___________________________________________________________________________ ABNER | F | F | MV | F | MV | *F ___________________________________________________________________________ BILL | F | F | F | F | MV | *F ___________________________________________________________________________ CHARLIE | MV | F | MV | F | MV | *MV ___________________________________________________________________________ DAVID | T | F | MV | T | MV | *MV ___________________________________________________________________________ EDWARD | T | F | F | T | MV | *F ___________________________________________________________________________ FRANK | T | F | T | T | MV | *T ___________________________________________________________________________ GEORGE | MV | T | MV | F | MV | *MV ___________________________________________________________________________ HARRY | T | T | MV | T | MV | *T ___________________________________________________________________________ IKE | T | T | F | T | MV | *F ___________________________________________________________________________ JOHN | T | T | T | T | MV | *T ___________________________________________________________________________
ABNER L0 = {NOT-AGE30, NOT-AGE60, NOT-URCOM} = {2-1, 3-1, 7-1}6. For a review of SET THEORY NOTATION (31,32,33), see Appendix B.
BILL L0 = {NOT-AGE30, NOT-AGE60, NOT-PSAG4, NOT-URCOM} = {2-1, 3-1, 5-1, 7-1}
CHARLIE L0 = {AGE60, NOT-URCOM} = {31, 7-1}
DAVID L0 = {AGE30, NOT-AGE60, URCOM} = {21, 3-1, 71}
EDWARD L0 = {AGE30, NOT-AGE60, PSAG4, URCOM} = {21, 3-1, 51, 71}
FRANK L0 = {AGE30, NOT-AGE60, PSAG4, URCOM} = {21, 3-1, 51, 71}
GEORGE L0 = {AGE60, NOT-URCOM} = {31, 7-1}
HARRY L0 = {AGE30, AGE60, URCOM} = {21, 31, 71}
IKE L0 = {AGE30, AGE60, NOT-PSAG4, URCOM} = {21, 31, 5-1, 71}
JOHN L0 = {AGE30, AGE60, PSAG4, URCOM} = {21, 31, 51, 71}
2, 3, 5, 7, 11, 13, 17, 19, 23, 29, 31, 37, 41, 43, 47, 53, 57, 59, 61, 67, 71,....Prime numbers form a natural ordering: the first prime number is always 2, the second prime number is always 3,.... the last prime number given above is: N=71, which is the mth (=21st) prime number. The fixed ordering of prime numbers can be used to keep track of the order of words in a mathematical statement, or the order of fields in a pathology database.
Then, a mathematical phrase such as "for every X there exists a unique Y...." would be Gödelized as:__________________________ | MATHEMATICAL | NUMERIC | | CONCEPT | LABEL | |__________________________| | FOR EVERY | 1 | |__________________________| | THERE EXISTS | 2 | |__________________________| | A UNIQUE | 3 | |__________________________| | X | 4 | |__________________________| | Y | 5 | |__________________________| | NOT | 6 | |__________________________| | AND | 7 | |__________________________| | OR | 8 | |__________________________| | ( | 9 | |__________________________| | ) | 10 | |__________________________|
2for every × 3X × 5there exists × 7a unique × 11Y = 21 × 34 × 52 × 73 × 1155. In a theorem known to EUCLID, every whole number can be uniquely reduced (FACTORED) down to its component primes and powers (34,35). In this example, 223,723,996,650 can always be uniquely factored obtain its prime-number components, namely:
= 223,723,996,650.
223,723,996,650 = 21 × 34 × 52 × 73 × 115The lookup table can, in turn, be used to reconstitute the original mathematical phrase:
2for every × 3X × 5there exists × 7a unique × 11YThis powerful property of prime number multiplication is used in mathematical arguments, but does not lend itself immediately to practical applications, because it involves arithmetic on huge numbers, and because factoring such numbers, while easy in principle, is computationally intense (so-called NP-complete and beyond (5,36,37).
2. The observed values for a particular patient are initially represented as powers of single prime numbers in a Gödel quotient, where: TRUE=1, FALSE=-1, MISSINGVALUE=0. Thus, for example, 21 means that the patient is greater than 30 years old; and 2-1 means that the patient is at most 30 years old.__________________________________________________ | FIELD | AGE30 | AGE60 | PSAG4 | URCOM | PROCA | |__________________________________________________| | PRIME | 2 | 3 | 5 | 7 | 11 | |__________________________________________________|
ABNER has the following Gödel quotientset as observed (Layer 0)data: ABNER L0 = {2-1, 3-1, 7-1}. That is, Abner is at most 30 years old; Abner is at most 60 years old (a redundant statement); and Abner has no urinary complaints.__________________________________________________ | FIELD | AGE30 | AGE60 | PSAG4 | URCOM | PROCA | |__________________________________________________| | PRIME | 2 | 3 | 5 | 7 | 11 | |__________________________________________________| | ABNER | F | F | MV | F | MV | |__________________________________________________|
JOHN has the following Gödel quotientset as observed data: JOHN L0 = {21, 31, 51, 71}. That is, John is greater than 30 years old; John is greater than 60 years old; John has PSA greater than 4; and John has urinary complaints.__________________________________________________ | FIELD | AGE30 | AGE60 | PSAG4 | URCOM | PROCA | |__________________________________________________| | PRIME | 2 | 3 | 5 | 7 | 11 | |__________________________________________________| | JOHN | T | T | T | T | MV | |__________________________________________________|
For example:#1. 2-1 3-1 5-1 7-1 11-1 #2. 2-1 3-1 5-1 7-1 111 #3. 2-1 3-1 5-1 71 11-1 #4. 2-1 3-1 5-1 71 111 #5. 2-1 3-1 51 7-1 11-1 #6. 2-1 3-1 51 7-1 111 ........ #32. 21 31 51 71 111
Truth-table-element-#1 is: NOT-2 IOR NOT-3 IOR NOT-5 IOR NOT-7 IOR NOT-11.
Truth-table-element-#2 is: NOT-2 IOR NOT-3 IOR NOT-5 IOR NOT-7 IOR 11.
Truth-table-element-#3 is: NOT-2 IOR NOT-3 IOR NOT-5 IOR 7 IOR NOT-11, etc.
Step 1. All user-suppled truths are computed Gödel quotients. Every qCQ is computed for Q, i.e., Q C ¢Q.
Step 2. All IOR covers are computed Gödel quotients. If q is computed for Q, then every cover of q is computed for Q, i.e., if qC¢Q and q « r, then rC¢Q.
Step 3. All flat-products are computed Gödel quotients. If q, r are computed for Q, then every FLAT-PRODUCT, q×r, is computed for Q, i.e., if q, rC¢Q, then q×rC¢Q.
Step 4. Ontology Layering Theorem. If p is uncertain in Q and p « q, then Q U {q} is consistent.
31
21 3-1
______________________
21
Then, for CHARLIE:
In Gödel quotient notation:__________________________________________________ | FIELD | AGE30 | AGE60 | PSAG4 | URCOM | PROCA | |__________________________________________________| | PRIME | 2 | 3 | 5 | 7 | 11 | |__________________________________________________| | CHARLIE | MV | T | F | F | MV | |__________________________________________________|
Charlie: 31
Ontology: 21 3-1
______________________
21
We can make the (obvious) inference that AGE30 is true, since AGE60 is true.
ABNER: 2-1
ABNER: 7-1
ONTOLOGY: 21 71 11-1
__________________________
11-1
If the three Gödel quotients are FLAT-MULTIPLIED,
then the flat-product is 11-1, i.e., NOT-PROCA.
Therefore one concludes that ABNER has no prostate cancer.
HEART HYPERTROPHY (HH=C0795691-C0333959)
____________________________________________
| | NOT-HH | HH | Total |
|___________________________________________|
| NOT-CPCL | 7,000 | 1,000 | 8,000 |
|___________________________________________|
| CPCL | 0 | 2,000 | 2,000 |
|___________________________________________|
| Total | 7,000 | 3,000 | 10,000 |
|___________________________________________|
CHRONIC-PASSIVE
-CONGESTION-LIVER
(CPCL=C0700148-C0721399).
ABNER L0 = {NOT-AGE30, NOT-AGE60, NOT-URCOM} = {2-1, 3-1, 7-1}2. For the prostate example in this report, there is one ABSOLUTE INFERENCE, placed at LAYER ONE, L1, namely, that:
BILL L0 = {NOT-AGE30, NOT-AGE60, NOT-PSAG4, NOT-URCOM} = {2-1, 3-1, 5-1, 7-1}
CHARLIE L0 = {AGE60, NOT-URCOM} = {31, 7-1}
DAVID L0 = {AGE30, NOT-AGE60, URCOM} = {21, 3-1, 71}
EDWARD L0 = {AGE30, NOT-AGE60, PSAG4, URCOM} = {21, 3-1, 51, 71}
FRANK L0 = {AGE30, NOT-AGE60, PSAG4, URCOM} = {21, 3-1, 51, 71}
GEORGE L0 = {AGE60, NOT-URCOM} = {31, 7-1}
HARRY L0 = {AGE30, AGE60, URCOM} = {21, 31, 71}
IKE L0 = {AGE30, AGE60, NOT-PSAG4, URCOM} = {21, 31, 5-1, 71}
JOHN L0 = {AGE30, AGE60, PSAG4, URCOM} = {21, 31, 51, 71}
L1: AGE60 IMPLIES AGE30This relationship may be expressed as an IOR relation, or as a Gödel quotient, as follows, where 2=AGE30 and 3=AGE60
IMPLICATION INCLUSIVE-OR GÖDEL QUOTIENT
L1: AGE60 IMPLIES AGE30 NOT-AGE60 IOR AGE30 21 3-1
L2: PROCA IMPLIES PSAG4For example, PROCA IMPLIES PSAG4 is considered more certain than PSAG4 IMPLIES PROCA, since PSAG4 is a measure of high turnover of prostate glandular epithelium, and many pathologic processes (infection, infarction, hyperplasia) can lead to this potentially non-specific result. Conversion to Gödel quotients yields: ®RM120¯
L3: (NOT-AGE30 AND NOT-URCOM) IMPLIES NOT-PROCA.
L4: PSAG4 IMPLIES PROCA
L5: (AGE60 AND URCOM) IMPLIES PROCA.
L6: (AGE30 AND URCOM) IMPLIES PSAG4.
IMPLICATION INCLUSIVE-OR GÖDEL QUOTIENT
L1: AGE60 IMPLIES AGE30. NOT-AGE60 IOR AGE30 21 3-1
L2: PROCA IMPLIES PSAG4. NOT-PROCA IOR PSAG4 51 11-1
L3: (NOT-AGE30 AND NOT-URCOM) AGE30 IOR URCOM 21 71 11-1
IMPLIES NOT-PROCA. IOR NOT-PROCA
L4: PSAG4 IMPLIES PROCA NOT-PSAG4 IOR PROCA 5-1 111
L5: (AGE60 AND URCOM) NOT-AGE60 IOR NOT-URCOM 3-1 7-1 111
IMPLIES PROCA IOR PROCA
L6: (AGE30 AND URCOM) NOT-AGE30 IOR NOT-URCOM 2-1 51 7-1
IMPLIES PSAG4 IOR PSAG4
®RM80¯
COVER
z z z z
| | | |
| | | |
| | | |
| y | | y |
| | | |
| |
| |
| |
| x |
| |
|
|
|
|
|
SUPPORT
(1) p « q, p-1 « r;Then: s is the FLAT-PRODUCT, q × r, if and only if:
(2) for every p'CP-{p,p-1} such that p' « q, p'-1 ~« r.
(3) for every p'CP-{p,p-1} such that p' « r, p'-1 ~« q.
(1) p ~« s, p-1 ~« s; .The exactly one prime factor described above permits an EXACT CANCELLATION. Consider the example:
(2) for every p'CP-{p,p-1} such that p' « q, p' « s;
(3) for every p'CP-{p,p-1} such that p' « r, p' « s.
In this example, there is exactly one pq = 2 3 51 r = 3 5-1 7 _____________________________ s = 2 3 50 7
(1) the set of every qCQ (USER-SUPPLIED TRUTHS);
(2) the set of every r » q such that qC¢Q (IOR INFERENCES);
and (3) the set of every s = q × r such that q, rC¢Q (FLAT-PRODUCTS).
Consider any tq = 2 3 51 r = 3 5-1 7 _____________________________ s = 2 3 50 7
All the above truth table elements belong to ðQ (Corollary 6). Furthermore, the following belong to ¢Q (Definition 8(3)):213-15-17-111-1 213-15-17-1111 213-15-171 11-1 213-15-171 111 213-151 7-111-1 213-151 7-1111 213-151 71 11-1 213-151 71 111
Likewise, the following belong to ðQ:213-15-17-1 213-15-171 213-151 7-1 213-151 71
Likewise, s belongs to ðQ. CONTRADICTION.213-15-1 213-151
1. Binary data.
2. Numeric data.
3. Categorical data.
4. Text comment or explanatory note.
You have a spouse; ANDA FALSE response to this compound sentence only means that at least one of the conditions is false. The status of the other two conditions would be determined from separate true/false statements.
you once beat your spouse; AND
you have stopped beating your spouse, true or false.
serum K < 1 mEq/dL. (T/F)This conversion is not particularly efficient, but it suggests a method in which conversion from numeric to binary data is always possible. Various computer algorithms can make the conversion more efficient. One simplification is to set break-points (thresholds) at below-normal, normal, above-normal, as for example:
serum K > 1 mEq/dL. (T/F)
serum K > 1.1 mEq/dL. (T/F)
serum K > 1.2 mEq/dL. (T/F)
serum K > 1.3 mEq/dL. (T/F)
serum K > 1.4 mEq/dL. (T/F)
serum K > 1.5 mEq/dL. (T/F) .........
serum K < 3.3 mEq/dL. (T/F)Another simplification is to set break-points at levels that would influence diagnostic or prognostic decisions.
serum K > 3.3 AND < 5.1 mEq/dL. (T/F)
serum K > 5.1 mEq/dL. (T/F)
>4.0 => >3.9.Therefore:
>3.9 => >3.8.
>3.8 => >3.7.
>3.7 => >3.6.
>3.6 => >3.5. ........
NOT->4.0 IOR >3.9.
NOT->3.9 IOR >3.8.
NOT->3.8 IOR >3.7.
NOT->3.7 IOR >3.6.
NOT->3.6 IOR >3.5. ........
ADENOCAPR: Adenocarcinoma, not otherwise specified.One of the mathematical properties of mutually exclusive categories is the set of rules that interrelate the corresponding binary variables, as for example:
PRDCTPRCA: Prostatic duct adenocarcinoma.
COLLOPRCA: Mucinous (colloid) adenocarcinoma.
SGNRNPRCA: Signet ring cell carcinoma.
ADNSQPRCA: Adenosquamous carcinoma.
SQMCLPRCA: Squamous cell carcinoma.
BASLOPRCA: Basaloid and adenoid cystic carcinoma.
TRANSPRCA: Transitional cell carcinoma.
SMLCLPRCA: Small cell carcinoma.
SARCOPRCA: Sarcomatoid carcinoma,
LYMEPPRCA: Lymphoepithelioma-like carcinoma.
UNDIFPRCA: Undifferentiated carcinoma, not otherwise specified.
ADENOCAPR => NOT-PRDCTPRCA.In IOR-notation:
ADENOCAPR => NOT-COLLOPRCA.
ADENOCAPR => NOT-SGNRNPRCA.
ADENOCAPR => NOT-ADNSQPRCA.
ADENOCAPR => NOT-SQMCLPRCA.
ADENOCAPR => NOT-BASLOPRCA.
ADENOCAPR => NOT-TRANSPRCA.
ADENOCAPR => NOT-SMLCLPRCA.
ADENOCAPR => NOT-SARCOPRCA.
ADENOCAPR => NOT-LYMEPPRCA.
ADENOCAPR => NOT-UNDIFPRCA.
PRDCTPRCA => NOT-COLLOPRCA.
PRDCTPRCA => NOT-SGNRNPRCA. ........
NOT-ADENOCAPR IOR NOT-PRDCTPRCA.
NOT-ADENOCAPR IOR NOT-COLLOPRCA.
NOT-ADENOCAPR IOR NOT-SGNRNPRCA.
NOT-ADENOCAPR IOR NOT-ADNSQPRCA.
NOT-ADENOCAPR IOR NOT-SQMCLPRCA.
NOT-ADENOCAPR IOR NOT-BASLOPRCA.
NOT-ADENOCAPR IOR NOT-TRANSPRCA.
NOT-ADENOCAPR IOR NOT-SMLCLPRCA.
NOT-ADENOCAPR IOR NOT-SARCOPRCA.
NOT-ADENOCAPR IOR NOT-LYMEPPRCA.
NOT-ADENOCAPR IOR NOT-UNDIFPRCA.
NOT-PRDCTPRCA IOR NOT-COLLOPRCA.
NOT-PRDCTPRCA IOR NOT-SGNRNPRCA. ........
6a. A SET IS CHARACTERIZED entirely in terms of its members, i.e., EXTENSIONALLY. A set may NOT be uniquely characterized INTENSIONALLY, i.e., by the manner of its creation. If two sets are created differently, but end up with the same membership, then they are the same set. For example, the set of humans living on the moon in 1850 and the set of Chevrolets built during 1850 are the same set, namely, the null set, Ø.Smith (12) believes that this classical formulation for sets is fundamentally flawed for describing ontologies, and has proposed using an alternate formulation, known as MEREOLOGY.
6b. A SET IS DIFFERENT FROM WHAT IT CONTAINS. that is, s and {s} are different. This property of sets leads to the Russell-Frege paradox: does the set of all sets belong to itself or not? (Is Epimenides a liar or not? (see Appendix C)). The Russell-Frege paradox can be resolved by defining two types of sets: ordinary sets and classes. This double definition involves a lot of extra mathematical bookkeeping.
1. Set membership, denotedC. We say that s is a member of S, denotedCS; or s is not a member of S, denoted ~CS;
2. The empty set, Ø, the set containing no members. There exists no s such that sCØ.
3. Set Union, U. The set A U B is the set of all members that belong either to set A or to set B or to both. Set union is analogous to inclusive-or (IOR) in first order propositional logic.
4. Set Intersection, /\. The set A /\ B is the set of all members that belong both to set A and to set B. Set intersection is analogous to logical AND in first order propositional logic.
5. Set Subtraction, -. The set A - B is the set of all members that belong to set A but NOT to set B. Set intersection is analogous to logical NOT in first order propositional logic.
6. Subset. ACB. We say that the set ACB, if the set of all members that belong to set A also belong to set B. Set intersection is analogous to IMPLIES in first order propositional logic.
(1) All men are mortal;If one knows that assertions (1) and (2) are true, then one is entitled to INFER that assertion (3) is true. This stepwise derivation of additional true statements from known true statements is a MATHEMATICAL PROOF.
(2) Socrates is a man;
(3) Therefore, Socrates is mortal.
http://www.netautopsy.org/cgi-bin/goedpath.cgiThe source code for this script is listed at URL:
http://www.netautopsy.org/goedpath.txtAn introduction to the Internet is given at URL:
http://www.netautopsy.org/whatnett.htmAn introduction to HTML and Perl is given at URL:
http://www.netautopsy.org/whatperl.htm
IMPLICATION INCLUSIVE-OR GÖDEL QUOTIENT
L1: AGE60 IMPLIES AGE30. NOT-AGE60 IOR AGE30 21 3-1
L2: PROCA IMPLIES PSAG4. NOT-PROCA IOR PSAG4 51 11-1
L3: (NOT-AGE30 AND NOT-URCOM) AGE30 IOR URCOM 21 71 11-1
IMPLIES NOT-PROCA. IOR NOT-PROCA
L4: PSAG4 IMPLIES PROCA NOT-PSAG4 IOR PROCA 5-1 111
L5: (AGE60 AND URCOM) PROCA NOT-AGE60 IOR NOT-URCOM 3-1 7-1 111
IMPLIES IOR PROCA
L6: (AGE30 AND URCOM) PROCA NOT-AGE30 IOR NOT-URCOM 2-1 51 7-1
IMPLIES IOR PSAG4
Solution: ABNER has NOT-PROCA._______________________________________________________ | FIELD | AGE30 | AGE60 | PSAG4 | URCOM | PROCA | |__________________________________________________|____ | PRIME | 2 | 3 | 5 | 7 | 11 | |__________________________________________________|____ | ABNER | F | F | MV | F | MV | *F |__________________________________________________|____
Abner (observed): 2-1 L3: 21 71 11-1 ___________________________________________________________________ Abner (calculated): 71 11-1 Abner (observed): 7-1 ___________________________________________________________________ Abner (calculated): 11-1
Solution: BILL has NOT-PROCA._______________________________________________________ | FIELD | AGE30 | AGE60 | PSAG4 | URCOM | PROCA | |__________________________________________________|____ | PRIME | 2 | 3 | 5 | 7 | 11 | |__________________________________________________|____ | BILL | F | F | F | T | MV | *F |__________________________________________________|____
Bill (observed): 5-1 L2: 51 11-1 ___________________________________________________________________ Bill (calculated): 11-1
_______________________________________________________ | FIELD | AGE30 | AGE60 | PSAG4 | URCOM | PROCA | |__________________________________________________|____ | PRIME | 2 | 3 | 5 | 7 | 11 | |__________________________________________________|____ | CHARLIE | MV | F | MV | T | MV | *MV |__________________________________________________|____
_______________________________________________________ | FIELD | AGE30 | AGE60 | PSAG4 | URCOM | PROCA | |__________________________________________________|____ | PRIME | 2 | 3 | 5 | 7 | 11 | |__________________________________________________|____ | DAVID | T | F | MV | T | MV | *T |__________________________________________________|____
David (observed): 21 L6: 2-1 51 7-1 ___________________________________________________________________ David (calculated): 51 7-1 David (observed): 71 ___________________________________________________________________ David (calculated): 51 L4: 5-1 111 ___________________________________________________________________ David (calculated): 51
_______________________________________________________ | FIELD | AGE30 | AGE60 | PSAG4 | URCOM | PROCA | |__________________________________________________|____ | PRIME | 2 | 3 | 5 | 7 | 11 | |__________________________________________________|____ | EDWARD | T | F | F | T | MV | *F |__________________________________________________|____
Edward (observed): 5-1 L2: 51 11-1 ___________________________________________________________________ Edward (calculated): 11-1
_______________________________________________________ | FIELD | AGE30 | AGE60 | PSAG4 | URCOM | PROCA | |__________________________________________________|____ | PRIME | 2 | 3 | 5 | 7 | 11 | |__________________________________________________|____ | FRANK | T | F | T | T | MV | *T |__________________________________________________|____
Frank (observed): 51 L4: 5-1 111 ___________________________________________________________________ Frank (calculated): 111
_______________________________________________________ | FIELD | AGE30 | AGE60 | PSAG4 | URCOM | PROCA | |__________________________________________________|____ | PRIME | 2 | 3 | 5 | 7 | 11 | |__________________________________________________|____ | GEORGE | MV | T | MV | F | MV | *MV |__________________________________________________|____
_______________________________________________________ | FIELD | AGE30 | AGE60 | PSAG4 | URCOM | PROCA | |__________________________________________________|____ | PRIME | 2 | 3 | 5 | 7 | 11 | |__________________________________________________|____ | HARRY | T | T | MV | T | MV | *T |__________________________________________________|____
Harry (observed): 31 L5: 3-1 7-1 111 ___________________________________________________________________ Harry (calculated): 7-1 111 Harry (observed): 71 ___________________________________________________________________ Harry (calculated): 111
_______________________________________________________ | FIELD | AGE30 | AGE60 | PSAG4 | URCOM | PROCA | |__________________________________________________|____ | PRIME | 2 | 3 | 5 | 7 | 11 | |__________________________________________________|____ | IKE | T | T | F | T | MV | *F |__________________________________________________|____
Ike (observed): 5-1 L6: 51 11-1 ___________________________________________________________________ Ike (calculated): 11-1
_______________________________________________________ | FIELD | AGE30 | AGE60 | PSAG4 | URCOM | PROCA | |__________________________________________________|____ | PRIME | 2 | 3 | 5 | 7 | 11 | |__________________________________________________|____ | JOHN | T | T | T | T | MV | *T |__________________________________________________|____
John (observed): 51 L6 : 5-1 111 ___________________________________________________________________ John (calculated): 111